cardiac catheterization.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: non-emergency catheterization of the femoral artery and catheter 6fr build a company; withdrawal of arterial sheath immediately after angiography; aged 18-65; systolic blood pressure less than 180 and a diastolic pressure of less than 100; the lack of bleeding disorders Off; Pt <16, ptt <50, INR <1/8; the absence of peripheral vascular disease; no history of previous low back pain; lack of experience difficulty passing urine; loss of cerebrovascular accidents and motor and neuromuscular problems; lack of angioseal, BMI 18/5-29; informed consent to participate in the study. Exclusion criteria: the need for angiography during cardiopulmonary resuscitation; chest pain with new ECG changes; hemodynamic changes associated with active bleeding and need for blood transfusion; dangerous arrhythmias immediately after cardiac catheterization; vascular injury during the procedure; hemostasis time after the procedure; a long (over 20 minutes); use of pain medications; heparin infusion during or after catheterization; manipulating both the femoral artery and arterial catheter in place for more than 2 times; patient unwillingness to participate in the study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bleeding. Timepoint: On arrival the patient, every 2 hours for 8 hours and then 24 hours later. Method of measurement: Christenson check list.;Hematoma. Timepoint: On arrival the patient, every 2 hours for 8 hours and then 24 hours later. Method of measurement: Christenson check list.;Pain. Timepoint: On arrival the patient, every 2 hours for 8 hours and then 24 hours later. Method of measurement: Numeric pain scale.;Urinary retention. Timepoint: On arrival the patient, every 2 hours for 8 hours and then 24 hours later. Method of measurement: Question of patient.;Comfort. Timepoint: On arrival the patient, every 2 hours for 8 hours and then 24 hours later. Method of measurement: Visual scale Comfort. | — |
Secondary
| Measure | Time frame |
|---|---|
| Protromobin time (PT). Timepoint: Before intervention. Method of measurement: second. | — |
Countries
Iran (Islamic Republic of)
Contacts
Golestan University of medical Sciences